BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 10638824)

  • 1. Iodinated PK 11195 as an ex vivo marker of neuronal injury in the lesioned rat brain.
    Chalon S; Pellevoisin C; Bodard S; Vilar MP; Besnard JC; Guilloteau D
    Synapse; 1996 Dec; 24(4):334-9. PubMed ID: 10638824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging of primary and remote ischaemic and excitotoxic brain lesions. An autoradiographic study of peripheral type benzodiazepine binding sites in the rat and cat.
    Dubois A; Bénavidès J; Peny B; Duverger D; Fage D; Gotti B; MacKenzie ET; Scatton B
    Brain Res; 1988 Mar; 445(1):77-90. PubMed ID: 2835123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of radioiodinated TISCH: a high-affinity and selective ligand for mapping CNS D1 dopamine receptor.
    Billings JJ; Kung MP; Chumpradit S; Mozley D; Alavi A; Kung HF
    J Neurochem; 1992 Jan; 58(1):227-36. PubMed ID: 1530770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is TISCH a suitable tracer for in vivo study of modifications of the dopamine D-1 receptor?
    Pellevoisin C; Chalon S; Kung HF; Besnard JC; Guilloteau D
    Nucl Med Biol; 1996 Jan; 23(1):75-8. PubMed ID: 9004918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and ex vivo autoradiography studies on peripheral-type benzodiazepine receptor binding using [11C]AC-5216 in normal and kainic acid-lesioned rats.
    Yanamoto K; Zhang MR; Kumata K; Hatori A; Okada M; Suzuki K
    Neurosci Lett; 2007 Nov; 428(2-3):59-63. PubMed ID: 17959307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioiodinated tracers for the evaluation of dopamine receptors in the neonatal rat brain after hypoxic-ischemic injury.
    Zouakia A; Chalon S; Kung HF; Dognon AM; Saliba E; Besnard JC; Guilloteau D
    Eur J Nucl Med; 1994 Jun; 21(6):488-92. PubMed ID: 8082661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of two radioiodinated ligands of dopamine D2 receptors in animal models: iodobenzamide and iodoethylspiperone.
    Pellevoisin C; Chalon S; Zouakia A; Dognon AM; Frangin Y; Baulieu JL; Besnard JC; Guilloteau D
    Life Sci; 1993; 52(23):1851-60. PubMed ID: 8502122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The distribution of radioactivity in brains of rats given [N-methyl-11C]PK 11195 in vivo after induction of a cortical ischaemic lesion.
    Cremer JE; Hume SP; Cullen BM; Myers R; Manjil LG; Turton DR; Luthra SK; Bateman DM; Pike VW
    Int J Rad Appl Instrum B; 1992 Feb; 19(2):159-66. PubMed ID: 1601669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Entorhinal cortex lesion or intrahippocampal colchicine injection increases peripheral type benzodiazepine binding sites in rat hippocampus.
    Baudry M; Altar CA
    Brain Res; 1991 Jul; 553(2):215-21. PubMed ID: 1657282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [3H]PK 11195 and the localisation of secondary thalamic lesions following focal ischaemia in rat motor cortex.
    Myers R; Manjil LG; Frackowiak RS; Cremer JE
    Neurosci Lett; 1991 Nov; 133(1):20-4. PubMed ID: 1791992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased densities of binding sites for the "peripheral-type" benzodiazepine receptor ligand [3H]PK11195 in vulnerable regions of the rat brain in thiamine deficiency encephalopathy.
    Leong DK; Le O; Oliva L; Butterworth RF
    J Cereb Blood Flow Metab; 1994 Jan; 14(1):100-5. PubMed ID: 8263044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo binding to peripheral benzodiazepine binding sites in lesioned rat brain: comparison between [3H]PK11195 and [18F]PK14105 as markers for neuronal damage.
    Price GW; Ahier RG; Hume SP; Myers R; Manjil L; Cremer JE; Luthra SK; Pascali C; Pike V; Frackowiak RS
    J Neurochem; 1990 Jul; 55(1):175-85. PubMed ID: 2355218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-(3-lodoprop-2E-enyl)-2beta-carbomethoxy-3beta-(3',4'-dichloro phenyl)nortropane (beta-CDIT), a tropane derivative: pharmacological characterization as a specific ligand for the dopamine transporter in the rodent brain.
    Garreau L; Emond P; Belzung C; Guilloteau D; Frangin Y; Besnard JC; Chalon S
    J Pharmacol Exp Ther; 1997 Jul; 282(1):467-74. PubMed ID: 9223589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotection of nerve growth factor-loaded microspheres on the D2 dopaminergic receptor positive-striatal neurones in quinolinic acid-lesioned rats: a quantitative autoradiographic assessment with iodobenzamide.
    Gouhier C; Chalon S; Venier-Julienne MC; Bodard S; Benoit J; Besnard J; Guilloteau D
    Neurosci Lett; 2000 Jul; 288(1):71-5. PubMed ID: 10869818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iodolisuride and iodobenzamide, two ligands for SPECT exploration of the dopaminergic D2 receptors: a comparative study.
    Pellevoisin C; Guilloteau D; Baulieu JL; Loc'h C; Dognon AM; Mauclaire L; Saccavini JC; Besnard JC; Chalon S
    Synapse; 1996 Sep; 24(1):79-86. PubMed ID: 9046079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage and astrocyte populations in relation to [3H]PK 11195 binding in rat cerebral cortex following a local ischaemic lesion.
    Myers R; Manjil LG; Cullen BM; Price GW; Frackowiak RS; Cremer JE
    J Cereb Blood Flow Metab; 1991 Mar; 11(2):314-22. PubMed ID: 1997503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative autoradiography of ligands for dopamine receptors and transporters in brain of Göttingen minipig: comparison with results in vivo.
    Minuzzi L; Olsen AK; Bender D; Arnfred S; Grant R; Danielsen EH; Cumming P
    Synapse; 2006 Mar; 59(4):211-9. PubMed ID: 16385509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The quantification of brain lesions with an omega 3 site ligand: a critical analysis of animal models of cerebral ischaemia and neurodegeneration.
    Benavides J; Capdeville C; Dauphin F; Dubois A; Duverger D; Fage D; Gotti B; MacKenzie ET; Scatton B
    Brain Res; 1990 Jul; 522(2):275-89. PubMed ID: 2171717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deficits in striatal dopamine D(2) receptors and energy metabolism detected by in vivo microPET imaging in a rat model of Huntington's disease.
    Araujo DM; Cherry SR; Tatsukawa KJ; Toyokuni T; Kornblum HI
    Exp Neurol; 2000 Dec; 166(2):287-97. PubMed ID: 11085894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-injurious behavior and dopaminergic neuron system in neonatal 6-hydroxydopamine-lesioned rat: 1. Dopaminergic neurons and receptors.
    Yokoyama C; Okamura H
    J Pharmacol Exp Ther; 1997 Feb; 280(2):1016-30. PubMed ID: 9023319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.